Paper41300969
Molecular Prognosticators Guiding Fertility-Sparing Surgery in Early-Stage Endometrial Cancer: A Comprehensive Review.
Shaikh S and 10 others. Cancers (Basel), 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Molecular Prognosticators Guiding Fertility-Sparing Surgery in Early-Stage Endometrial Cancer: A Comprehensive Review. Papers, record 41300969. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41300969
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Molecular Prognosticators Guiding Fertility-Sparing Surgery in Early-Stage Endometrial Cancer: A Comprehensive Review.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References99
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24388202 | Prognostic factors of oncologic and reproductive outcomes in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma: systematic review and meta-analysis. | Fertil Steril | 2014 | https://conductscience.org/library/papers/24388202 | PubMed |
| 2 | 39235934 | Understanding risk factors for endometrial cancer in young women. | J Natl Cancer Inst | 2025 | https://conductscience.org/library/papers/39235934 | PubMed |
| 3 | 33039397 | Mismatch repair status influences response to fertility-sparing treatment of endometrial cancer. | Am J Obstet Gynecol | 2021 | https://conductscience.org/library/papers/33039397 | PubMed |
| 4 | 23636398 | Integrated genomic characterization of endometrial carcinoma. | Nature | 2013 | https://conductscience.org/library/papers/23636398 | PubMed |
| 5 | 34607827 | Correction: Improving response to progestin treatment of low-grade endometrial cancer. | Int J Gynecol Cancer | 2021 | https://conductscience.org/library/papers/34607827 | PubMed |
| 6 | 35274725 | Perspectives of Young Women With Gynecologic Cancers on Fertility and Fertility Preservation: A Systematic Review. | Oncologist | 2022 | https://conductscience.org/library/papers/35274725 | PubMed |
| 7 | 35269674 | Fertility-Sparing Approaches in Atypical Endometrial Hyperplasia and Endometrial Cancer Patients: Current Evidence and Future Directions. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35269674 | PubMed |
| 8 | 31056702 | ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach. | Ann Oncol | 2019 | https://conductscience.org/library/papers/31056702 | PubMed |
| 9 | 31846532 | Incorporation of molecular characteristics into endometrial cancer management. | Histopathology | 2020 | https://conductscience.org/library/papers/31846532 | PubMed |
| 10 | 36358604 | Endometrial Cancer in Reproductive Age: Fertility-Sparing Approach and Reproductive Outcomes. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36358604 | PubMed |
| 11 | 36690721 | Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry. | Br J Cancer | 2023 | https://conductscience.org/library/papers/36690721 | PubMed |
| 12 | 33251877 | Dostarlimab in the treatment of recurrent or primary advanced endometrial cancer. | Future Oncol | 2021 | https://conductscience.org/library/papers/33251877 | PubMed |
| 13 | 33205638 | Fertility-sparing management for endometrial cancer: review of the literature. | Minerva Med | 2021 | https://conductscience.org/library/papers/33205638 | PubMed |
| 14 | 38540726 | Reproductive and Oncologic Outcomes in Young Women with Stage IA and Grade 2 Endometrial Carcinoma Undergoing Fertility-Sparing Treatment: A Systematic Review. | Biomolecules | 2024 | https://conductscience.org/library/papers/38540726 | PubMed |
| 15 | 28352680 | Endometrial cancer and microsatellite instability status. | Open Med (Wars) | 2015 | https://conductscience.org/library/papers/28352680 | PubMed |
| 16 | 34830129 | Fertility Sparing Treatments in Endometrial Cancer Patients: The Potential Role of the New Molecular Classification. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34830129 | PubMed |
| 17 | 23744837 | Progesterone receptor signaling in the microenvironment of endometrial cancer influences its response to hormonal therapy. | Cancer Res | 2013 | https://conductscience.org/library/papers/23744837 | PubMed |
| 18 | 24844595 | POLE exonuclease domain mutation predicts long progression-free survival in grade 3 endometrioid carcinoma of the endometrium. | Gynecol Oncol | 2014 | https://conductscience.org/library/papers/24844595 | PubMed |
| 19 | 36756380 | ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma. | Hum Reprod Open | 2023 | https://conductscience.org/library/papers/36756380 | PubMed |
| 20 | 35269800 | Biomolecular and Genetic Prognostic Factors That Can Facilitate Fertility-Sparing Treatment (FST) Decision Making in Early Stage Endometrial Cancer (ES-EC): A Systematic Review. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35269800 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42940054 | Association of VCP/p97 Expression with Clinicopathological Features and Overall Survival in Endometrioid Endometrial Carcinoma. | Biomedicines | 2026 | https://conductscience.org/library/papers/42940054 | PubMed |
| 42755554 | Molecular classification of endometrial cancer in fertility-sparing-treatment: toward a personalized clinical approach. | Front Oncol | 2026 | https://conductscience.org/library/papers/42755554 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41300969
GET https://conductscience.org/api/papers/v1/41300969/references?page=2